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EBV is a human herpes virus that infects B cells and epithelial cells to establish a latent 
infection. It is associated with many malignant diseases such as Burkitt’s lymphoma, 
nasopharyngeal carcinoma and gastric carcinoma. TPA is a protein kinase C activator and tumor 
promoter, it can induce EBV reactivation. However, the molecular mechanism of EBV 
reactivation remains unknown. Previously the authors found that nitric oxide (NO) inhibited 
EBV reactivation and TPA inhibited iNOS expression in EBV infected gastric epithelial cell line 
GT38. This study has characterized the intracellular signaling pathways by which TPA induces 
EBV reactivation in GT38 cells. Spontaneous EBV reactivation became undetectable upon 
long-term culturing of GT38 cells, while iNOS mRNA expression as a marker of NO production 
increased. The PKC inhibitors H7 and staurosporine and MAPK inhibitor PD98059 inhibited 
TPA-induced expression of EBV immediate early genes BZLF1 and BRLF1 and reversed 
TPA-mediated inhibition of iNOS gene expression. NF-B and AP-1 were also activated by TPA in 
a time-dependent manner. The TPA-induced NF-B activation and BZLF1 expression were 
inhibited by pretreatment with NF-B inhibitor pyrrolidine dithiocarbamate (PDTC). These 
results demonstrats that TPA induces EBV reactivation via NF-B and AP-1 and that PKC is an 
important mediator in regulating gene expression leading to EBV reactivation after TPA 
treatment of GT38 cells. 
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GT38 cells were grown in RPMI 1640 medium, supplemented with 10% fetal bovine serum. 
Total RNA from cells was prepared by an ISOGEN kit. BZLF1, c-jun or junB mRNA were detected 
by Northern blot analysis. iNOS mRNA expression was analysed by RT-PCR Southern blotting. 
ZEBRA was detected by Western blot analysis using anti-ZEBRA antibody. Nuclear transcription 
factors NF-kB and AP-1 were analyzed by electrophoretic mobility shift assays. 
⤖ ᯝ
   The expression of ZEBRA was highest in GT38-96 cells , and it was much higher in GT38-97 
cells than in GT38-98 cells. In contrast to ZEBRA, iNOS mRNA expression was highest in 
GT38-98 cells, and it was much higher in GT38-97 cells than in GT38-96 cells. TPA-induced 
expressions of BZLF1 and BRLF1 were greatly inhibited by pretreatment with H7 , staurosporine 
or PD98059. On the other hand, TPA markedly inhibited iNOS mRNA expression and that 
inhibition could be reversed by pretreatment with H7, staurosporine, and PD98059. NF-B
binding activity rapidly increased and peaked at 0.5 h after TPA treatment. TPA treatment 
further increased the level of activated AP-1 in the nuclear extracts. NF-B inhibitor, PDTC 
inhibits NF-B activity and BZLF1 expression. c-Jun was increased significantly at 0.5 h, reached 
a peak at 2 h, and declined to a low level at 24 h after TPA stimulation. junB was increased 
slightly at 0.5 h, reached a plateau at 1 h, and maintained a high level at least until 24 h after 
TPA treatment.  
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This study investigated the molecular mechanisms by which TPA inhibits iNOS gene 
expression and induces EBV reactivation in the gastric tissue derived epithelial cell line GT38 
cells firstly. This paper demonstrated that the expression of ZEBRA was highest in GT38-96 cells. 
In contrast to ZEBRA, iNOS mRNA expression was highest in GT38-98 cells. Secondly the paper 
demonstrated that the involvement of PKC pathway in TPA-induced EBV reactivation. This 
observation has led to a better insight into the signal transduction pathway associated with EBV 
reactivation. The results indicate that TPA can induce AP-1 binding activity, suggesting that 
BZLF1 expression might be regulated by AP-1. NF-B is also involved in the up-regulation of 
BZLF1 by TPA treatment, and the BZLF1 promoter domain might also contain binding sites for 
the transcription factor NF-B. Regulation of the BZLF1 and BRLF1 promoters in GT38 cells may 
be mediated, in part, through a homodimer of c-Jun or c-Jun/JunB heterodimer.  
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 This study, for the first time, demonstrates that TPA-induced EBV reactivation can occur by 
activating NF-B and AP-1, and suggests that this reactivation, marked by BZLF1 expression, is 
likely to be mediated at least via both PKC and MAPK pathways in the gastric tissue-derived 
epithelial cell line GT38. 
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